Palvella Therapeutics, Inc (PVLA) — Defensive Interval Ratio

Latest as of June 2026: 1918 days

Palvella Therapeutics, Inc (PVLA) has a Defensive Interval Ratio of 1918 days as of June 2026. Defensive assets of $62.78 Million (cash $-, short-term investments $62.78 Million, receivables $-) cover 1918 days of daily cash needs of $32.73K/day.

Defensive Interval Ratio

1918 days
Days of operational coverage

Defensive Assets

$62.78 Million
Cash + ST Investments + Receivables

Daily Cash Need

$32.73K
Current Liabilities ÷ 365

Current Liabilities

$11.95 Million
USD

Palvella Therapeutics, Inc Defensive Interval Ratio (2020–2025)

This chart shows how Palvella Therapeutics, Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 1918 days, meaning defensive assets of $62.78 Million can fund 1918 days of operations without new revenue. For the complete balance sheet picture, see PVLA current and non-current assets.

Annual Defensive Interval Ratio for Palvella Therapeutics, Inc (2020–2025)

The table below presents the year-by-year Defensive Interval Ratio for Palvella Therapeutics, Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is Palvella Therapeutics, Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 0 days $0.00 $31.08K/day $- $- ▼ -71 days
2024 71 days $2.34 Million $32.98K/day $- $- ▲ +71 days
2023 0 days $0.00 $6.47K/day $- $- ▼ -1663 days
2022 1663 days $26.34 Million $15.84K/day $- $20.53 Million ▲ +1639 days
2021 24 days $3.31 Million $138.52K/day $- $- ▼ -4 days
2020 28 days $1.71 Million $60.67K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)